Karyopharm Therapeutics Inc (KPTI)
0.8612
-0.07
(-7.42%)
USD |
NASDAQ |
Nov 05, 09:51
Karyopharm Therapeutics Max Drawdown (5Y): 97.56% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.56% |
| September 30, 2024 | 97.56% |
| August 31, 2024 | 97.56% |
| July 31, 2024 | 97.56% |
| June 30, 2024 | 97.56% |
| May 31, 2024 | 97.56% |
| April 30, 2024 | 97.56% |
| March 31, 2024 | 97.56% |
| February 29, 2024 | 97.56% |
| January 31, 2024 | 97.56% |
| December 31, 2023 | 97.56% |
| November 30, 2023 | 97.56% |
| October 31, 2023 | 97.11% |
| September 30, 2023 | 95.89% |
| August 31, 2023 | 95.38% |
| July 31, 2023 | 94.62% |
| June 30, 2023 | 93.54% |
| May 31, 2023 | 91.99% |
| April 30, 2023 | 91.26% |
| March 31, 2023 | 91.26% |
| February 28, 2023 | 91.26% |
| January 31, 2023 | 91.26% |
| December 31, 2022 | 91.26% |
| November 30, 2022 | 91.26% |
| October 31, 2022 | 91.26% |
| Date | Value |
|---|---|
| September 30, 2022 | 91.26% |
| August 31, 2022 | 91.26% |
| July 31, 2022 | 91.26% |
| June 30, 2022 | 91.26% |
| May 31, 2022 | 91.26% |
| April 30, 2022 | 91.26% |
| March 31, 2022 | 91.26% |
| February 28, 2022 | 91.26% |
| January 31, 2022 | 91.26% |
| December 31, 2021 | 91.26% |
| November 30, 2021 | 91.26% |
| October 31, 2021 | 91.26% |
| September 30, 2021 | 91.26% |
| August 31, 2021 | 91.26% |
| July 31, 2021 | 91.26% |
| June 30, 2021 | 91.26% |
| May 31, 2021 | 91.26% |
| April 30, 2021 | 91.26% |
| March 31, 2021 | 91.26% |
| February 28, 2021 | 91.26% |
| January 31, 2021 | 91.26% |
| December 31, 2020 | 91.26% |
| November 30, 2020 | 91.26% |
| October 31, 2020 | 91.26% |
| September 30, 2020 | 91.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
91.26%
Minimum
Nov 2019
97.56%
Maximum
Nov 2023
92.87%
Average
91.26%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -43.37 |
| Beta (5Y) | 0.1573 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 74.46% |
| Historical Sharpe Ratio (5Y) | -0.5552 |
| Historical Sortino (5Y) | -0.9707 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.03% |